EUVIMEDSkopri EUVIMED
Crossref

Cochlear Implantation in Neurofibromatosis Type 2‐Related Schwannomatosis: Long‐Term Hearing Outcomes

Baptiste Grenier, Isabelle Mosnier iD, Evelyne Ferrary iD, Yann Nguyen iD, Olivier Sterkers iD, Michel Kalamarides iD, Ghizlene Lahlou iD, Hannah Daoudi iD

Otolaryngology–Head and Neck Surgery · 2024

DOI: 10.1002/ohn.702 ↗

At a glance

Journal article in Otolaryngology–Head and Neck Surgery, 2024. Written by Baptiste Grenier and 7 co-authors. Institution: ENT Department, La Pitié-Salpêtrière, APHP, Sorbonne University, Paris, France. Major MEDLINE topics: Neurofibromatosis 2, Cochlear Implantation, Neurofibromatoses. Cited 5 times so far (Crossref); 57 references.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Objective

To evaluate long‐term hearing outcomes following cochlear implantation in patients with neurofibromatosis type 2 and ipsilateral vestibular schwannoma. Study Design Retrospective study.

Setting

Tertiary general hospital.

Methods

Twenty‐two patients undergoing cochlear implantation between 2004 and 2018 with at least 1 year of follow‐up were included. Patients were categorized as “users” or “nonusers” of their cochlear implant (CI). For users, speech perception (disyllabic words) without lip‐reading was assessed in quiet conditions 1‐year postimplantation, and annually thereafter. CI users were classified into 2 groups on the basis of speech intelligibility (≥40% or

Subjects

MeSH terms (MEDLINE)

Neurofibromatosis 2Cochlear ImplantationNeurofibromatosesHumansMaleRetrospective StudiesFemaleMiddle AgedAdultSpeech PerceptionTreatment OutcomeSkin NeoplasmsAgedNeurilemmomaNeuroma, AcousticSpeech IntelligibilityFollow-Up Studies

Author keywords

NF2auditory outcomescochlear implanthearing rehabilitationvestibular schwannoma

Authors and institutions

  • ENT Department, La Pitié-Salpêtrière, APHP, Sorbonne University, Paris, France.
  • Technologies and Gene Therapy for Deafness, Hearing Institute, Pasteur Institute/Inserm /Université Paris Cité, Paris, France.
  • Neurosurgery Department, Pitié-Salpêtrière, APHP, Sorbonne University, Paris, France.
  • Genetics and Development of Brain Tumors, CRICM Inserm U1127 CNRS UMR 7225, Paris Brain Institute, Paris, France.

ORCID profiles: Isabelle Mosnier, Evelyne Ferrary, Yann Nguyen, Olivier Sterkers, Michel Kalamarides, Ghizlene Lahlou, Hannah Daoudi

Cite

APA

Grenier, B., Mosnier, I., Ferrary, E., Nguyen, Y., Sterkers, O., Kalamarides, M., Lahlou, G., & Daoudi, H. (2024). Cochlear Implantation in Neurofibromatosis Type 2‐Related Schwannomatosis: Long‐Term Hearing Outcomes. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.702

Vancouver

Grenier B, Mosnier I, Ferrary E, Nguyen Y, Sterkers O, Kalamarides M, et al. Cochlear Implantation in Neurofibromatosis Type 2‐Related Schwannomatosis: Long‐Term Hearing Outcomes. Otolaryngology–Head and Neck Surgery. 2024. doi:10.1002/ohn.702

BibTeX
@article{Grenier2024,
  author = {Grenier, Baptiste and Mosnier, Isabelle and Ferrary, Evelyne and Nguyen, Yann and Sterkers, Olivier and Kalamarides, Michel and Lahlou, Ghizlene and Daoudi, Hannah},
  title = {Cochlear Implantation in Neurofibromatosis Type 2‐Related Schwannomatosis: Long‐Term Hearing Outcomes},
  journal = {Otolaryngology–Head and Neck Surgery},
  year = {2024},
  doi = {10.1002/ohn.702}
}
Start for free →